In this study, we observed that DDX49 was highly expressed in CRC tissues, with its expression level significantly correlating with adverse clinicopathological features (including tumor stage and lymph node metastasis) and worse patient survival. This evidence concerns the gene DDX49 and colorectal carcinoma.